Combining PDT and Avastin for wet AMD

Article

ONE-YEAR FOLLOW-UP OF COMBINED CUSTOMIZED THERAPY. PHOTODYNAMIC THERAPY AND BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

ONE-YEAR FOLLOW-UP OF COMBINED CUSTOMIZED THERAPY. PHOTODYNAMIC THERAPY AND BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Please click here to read the full story.

Recent Videos
3 experts are featured in this series.
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.